SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-20-117957
Filing Date
2020-10-26
Accepted
2020-10-26 06:40:57
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-1/A tm2033419d2_s1a.htm S-1/A 310874
2 EXHIBIT 4.10 tm2033419d2_ex4-10.htm EX-4.10 198198
3 EXHIBIT 4.11 tm2033419d2_ex4-11.htm EX-4.11 20304
4 EXHIBIT 23.1 tm2033419d2_ex23-1.htm EX-23.1 2438
5 GRAPHIC tm2033419d2_s1img01.jpg GRAPHIC 12900
  Complete submission text file 0001104659-20-117957.txt   550753
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-249550 | Film No.: 201258984
SIC: 2836 Biological Products, (No Diagnostic Substances)